Radiation Oncology Strategic Biomarker Initiative Laboratory
Simona Shaitelman, M.D.
Gabriel Sawakuchi, Ph.D.
- Departments, Labs and Institutes
- Radiation Oncology Strategic Biomarker Initiative Laboratory
Areas of Research
- Cancer Biology Research
- Genetics Research
- Radiation Oncology
The purpose of the Radiation Oncology Strategic Biomarker Initiative is to establish a centralized, uniform and robust process for biospecimen collection, cataloging, processing, and storage across different clinical trials in radiation oncology.
There is an unmet need to develop strategies to predict radiation response. The degree of radiation response in malignant tumors and normal tissue can be affected by a variety of factors including mutations, the tumor microenvironment, microbiome, and the immune system. These factors need to be studied from patient samples to develop models that will help predict radiation response.
Our goal is to enable clinicians and researchers of the Radiation Oncology division at MD Anderson to develop predictors of radiation response utilizing biomarkers that can be implemented in the clinical setting to improve patient outcomes and reduce treatment toxicities while merging clinical and technical innovations with advances in the biologic and mechanistic understanding of radiation.
The facility is located on the 7th floor of the Zayed Research Building, Z7.4028.
Please direct all inquiries to ROBiomarkerInitiative@mdanderson.org.